Companies Dominating the Glycomics/Glycobiology Landscape
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Companies involved in the global market are unfolding remarkable growth opportunities, seeking support from regulatory frameworks. In this regard, the U.S. and Europe-based firms are focusing on biopharmaceutical collaborations to expand their market share. Thermo Fisher and Agilent are leading the market through AI-based glycan platforms that have resulted in a substantial market share reflecting technological adoption. Besides the focus on affordable diagnostics coupled with mergers and acquisitions collectively support the market landscape in this sector.
Here is the list of some prominent players in the industry:
|
Company Name |
Country |
Market Share (2024) |
|
Thermo Fisher Scientific |
USA |
20% |
|
Agilent Technologies |
USA |
15% |
|
Merck KGaA |
Germany |
12% |
|
Waters Corporation |
USA |
10% |
|
Shimadzu Corporation |
Japan |
9% |
|
Bruker Corporation |
USA |
xx% |
|
Danaher Corporation |
USA |
xx% |
|
Takara Bio |
Japan |
xx% |
|
Ludger Ltd |
UK |
xx% |
|
New England Biolabs |
USA |
xx% |
|
S-BIO |
South Korea |
xx% |
|
ProZyme |
USA |
xx% |
|
GlycoSolutions |
Australia |
xx% |
|
Dextra Laboratories |
UK |
xx% |
|
RayBiotech |
USA |
xx% |
|
Z Biotech |
Germany |
xx% |
|
Bio-Techne |
USA |
xx% |
|
Premas Biotech |
India |
xx% |
|
GlycoNex |
Taiwan |
xx% |
|
Malaysian Glycomics Consortium |
Malaysia |
xx% |
Below are the areas covered for each company under the top 15 global manufacturers: